Source: Annual Congress 2010 - The prognosis of community-acquired pneumonia: old and new markers of severity
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
A. B. Lasierra, S. Fandos, E. Mincholé, D. Nieto, L. Martinez, A. Boldova, A. García de Jalón, S. Bello (Zaragoza, Spain). Community acquired pneumonia (CAP) 30 days mortality and biomarkers. Eur Respir J 2010; 36: Suppl. 54, 2218

Member's Comments

No comment yet.

Related content which might interest you: Community acquired pneumonia (CAP) mortality and biomarkers Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia Year: 2011 Community acquired pneumonia (CAP). Mortality prediction using the BTS-rule Source: Eur Respir J 2004; 24: Suppl. 48, 413s Year: 2004 Community acquired pneumonia (CAP) and PSI mortality risk stratification Source: Eur Respir J 2004; 24: Suppl. 48, 413s Year: 2004 Biological markers in hospitalised patients with community acquired pneumonia (CAP) Source: Annual Congress 2010 - The spectrum of lower respiratory tract infections: risk factors of poor outcome and diagnostic tools Year: 2010 Biomarkers and community acquired pneumonia (CAP) severity Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia Year: 2011 Biomarkers and community acquired pneumonia (CAP) severity Source: Annual Congress 2010 - The prognosis of community-acquired pneumonia: old and new markers of severity Year: 2010 A delay in reaching time to clinical stability (tcs) for hospitalized patients with community-acquired pneumonia (CAP) is associated with failure within 30 days after hospital discharge Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia Year: 2009 Use of pneumonia severity index in Spain to decide hospitalization among patients with community-acquired pneumonia (CAP). (Nacar Study) Source: Eur Respir J 2005; 26: Suppl. 49, 637s Year: 2005 Definition of severity and the reasons for hospitalization (RH) in patients with community-acquired pneumonia (CAP) Source: Eur Respir J 2005; 26: Suppl. 49, 641s Year: 2005 Surfactant protein D (SPD) like marker of effectiveness ofphosphatidylcholine treatment outcomes in patients (pts) with community acquired pneumonia (CAP) Source: International Congress 2015 – Healthcare organisation and appropriateness in lung disorders Year: 2015 Clinical judgement on top of CURB65-score in predicting 30 days clinical outcome in patients with community acquired pneumonia (CAP) admitted to the hospital Source: International Congress 2014 – Pathogenesis and mechanisms of respiratory infections Year: 2014 Cardiac diseases in patients with community acquired pneumonia (CAP) Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections Year: 2012 I-ROAD could be efficient in predicting severity of community acquired pneumonia (CAP) or healthcare-associated-pneumonia(HCAP) Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients Year: 2010 Health care associated pneumonia (HCAP) and community acquired pneumonia (CAP): Are they different diseases? Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients Year: 2010 Mortality directly related to community-acquired pneumonia (CAP) in hospitalized patients: results from the community-acquired pneumonia organization (CAPO) international cohort study Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia Year: 2007 Correlation between pneumonia severity index and mortality within 30 days after the diagnosis of community-acquired pneumonia in elderly subjects Source: Eur Respir J 2006; 28: Suppl. 50, 741s Year: 2006 Comparison of prospective scores for predicting mortality and hospital admission in hospitalised patients and out-patients with CAP Source: Annual Congress 2005 - Community-acquired pneumonia: clinical approaches Year: 2005 Hyperglycaemia in children with community acquired pneumonia (CAP) Source: Eur Respir J 2003; 22: Suppl. 45, 318s Year: 2003 Inflammatory biomarkers in predicting ICU admission of severe community-acquired pneumonia (CAP) Source: Annual Congress 2011 - Pulmonary infections and sepsis Year: 2011 Progress of quality indicator rates regarding treatment of patients hospitalized in Germany due to community acquired pneumonia (CAP) Source: Annual Congress 2010 - The spectrum of lower respiratory tract infections: risk factors of poor outcome and diagnostic tools Year: 2010